Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circulating tumour DNA biomarkers in savolitinib-treated patients with non-small cell lung cancer harbouring MET exon 14 skipping alterations: a post hoc analysis of a pivotal phase 2 study. | Ther Adv Med Oncol | 2022 | 36339926 | PubTator, text mining | PubMed |
| Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling. | Leuk Res | 2022 | 36332294 | PubTator, text mining | PubMed |
| A clinical report on high‑dose cytarabine therapy for children with acute myeloid leukemia. | Mol Clin Oncol | 2022 | 36325296 | PubTator, text mining | PubMed |
| MicroRNA profiling of paediatric AML with FLT-ITD or MLL-rearrangements: Expression signatures and in vitro modulation of miR-221-3p and miR-222-3p with BRD4/HATs inhibitors. | Oncol Rep | 2022 | 36321792 | PubTator, text mining | PubMed |
| Outcome of autologous stem cell transplantation in patients with favorable-risk acute myeloid leukemia in first remission. | Cancer Cell Int | 2022 | 36316734 | PubTator, text mining | PubMed |
| Progress of phototherapy for osteosarcoma and application prospect of blue light photobiomodulation therapy. | Front Oncol | 2022 | 36313662 | PubTator, text mining | PubMed |
| The prognostic marker FLVCR2 associated with tumor progression and immune infiltration for acute myeloid leukemia. | Front Cell Dev Biol | 2022 | 36313565 | PubTator, text mining | PubMed |
| Distinct clinicopathological characteristics, genomic alteration and prognosis in breast cancer with concurrent TP53 mutation and MYC amplification. | Thorac Cancer | 2022 | 36305094 | PubTator, text mining | PubMed |
| Targeting UHRF1-SAP30-MXD4 axis for leukemia initiating cell eradication in myeloid leukemia. | Cell Res | 2022 | 36302855 | PubTator, text mining | PubMed |
| Targeting Apoptosis in AML: Where Do We Stand? | Cancers (Basel) | 2022 | 36291779 | PubTator, text mining | PubMed |
| Identification of the Thyrotropin-Releasing Hormone (TRH) as a Novel Biomarker in the Prognosis for Acute Myeloid Leukemia. | Biomolecules | 2022 | 36291567 | PubTator, text mining | PubMed |
| Subtype-specific 3D genome alteration in acute myeloid leukaemia. | Nature | 2022 | 36289338 | PubTator, text mining | PubMed |
| Understanding a high-risk acute myeloid leukemia by analyzing the interactome of its major driver mutation. | PLoS Genet | 2022 | 36288392 | PubTator, text mining | PubMed |
| A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for acute myeloid leukemia. | Front Oncol | 2022 | 36276132 | PubTator, text mining | PubMed |
| Treatment options for acute myeloid leukemia patients aged <60 years. | Front Oncol | 2022 | 36276074 | PubTator, text mining | PubMed |
| Competing endogenous RNA networks related to prognosis in chronic lymphocytic leukemia: comprehensive analyses and construction of a novel risk score model. | Biomark Res | 2022 | 36271413 | PubTator, text mining | PubMed |
| LINC00958 Inhibits Autophagy of Bladder Cancer Cells via Sponge Adsorption of miR-625-5p to Promote Tumor Angiogenesis and Oxidative Stress. | Oxid Med Cell Longev | 2022 | 36262285 | PubTator, text mining | PubMed |
| Prognostic Factors in Acute Myeloid Leukemia with t(8;21)/AML1-ETO: Strategies to Define High-Risk Patients. | Indian J Hematol Blood Transfus | 2022 | 36258727 | PubTator, text mining | PubMed |
| Peripheral blood marker of residual acute leukemia after hematopoietic cell transplantation using multi-plex digital droplet PCR. | Front Immunol | 2022 | 36248870 | PubTator, text mining | PubMed |
| Diagnostic challenges in acute monoblastic/monocytic leukemia in children. | Front Pediatr | 2022 | 36245718 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=29